Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ME

23andMe (ME)

23andMe Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ME
DateTimeSourceHeadlineSymbolCompany
1:02PMiHub NewswireFeaturedMawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt
09/18/20248:10AMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
09/18/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
09/18/20246:13AMIH Market NewsMeta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates SpectaclesNASDAQ:ME23andMe Holding Company
09/17/20244:26PMGlobeNewswire Inc.Independent Directors of 23andMe Resign from BoardNASDAQ:ME23andMe Holding Company
09/15/20243:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 TrialNASDAQ:ME23andMe Holding Company
09/15/20243:00AMGlobeNewswire Inc.23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 StudyNASDAQ:ME23andMe Holding Company
09/12/20244:05PMGlobeNewswire Inc.One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All PopulationsNASDAQ:ME23andMe Holding Company
09/12/20246:02AMIH Market NewsNorfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition ProposalsNASDAQ:ME23andMe Holding Company
09/11/20244:45PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
09/03/20247:30AMGlobeNewswire Inc.23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024NASDAQ:ME23andMe Holding Company
08/28/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
08/28/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
08/28/20247:30AMGlobeNewswire Inc.Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership ProgramNASDAQ:ME23andMe Holding Company
08/27/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/21/20245:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
08/21/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
08/08/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
08/08/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/08/20244:05PMGlobeNewswire Inc.23andMe Reports First Quarter Fiscal 2025 Financial ResultsNASDAQ:ME23andMe Holding Company
08/05/20245:43AMIH Market NewsNvidia AI Chip Delays, Mars Eyes Kellanova Acquisition, Berkshire Hathaway’s Cash Surge to $277 BillionNASDAQ:ME23andMe Holding Company
08/02/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/02/20248:00AMGlobeNewswire Inc.23andMe Special Committee responds to CEO’s take-private proposalNASDAQ:ME23andMe Holding Company
08/01/20248:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/01/20248:00AMGlobeNewswire Inc.23andMe Announces CEO’s Take-Private ProposalNASDAQ:ME23andMe Holding Company
07/31/20245:01PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ME23andMe Holding Company
07/25/20244:45PMGlobeNewswire Inc.23andMe to Report Q1 FY2025 Financial ResultsNASDAQ:ME23andMe Holding Company
07/25/20247:30AMGlobeNewswire Inc.Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance ResearchNASDAQ:ME23andMe Holding Company
07/16/20244:54PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ME23andMe Holding Company
07/16/20244:53PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME

Your Recent History

Delayed Upgrade Clock